R
Royalty Pharma plc (RPRX)
NMS – Real vaqt narxi. Valyuta: USD
56.23
+1.54 (2.82%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
56.01
-0.22 (-0.39%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
56.23
+1.54 (2.82%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
56.01
-0.22 (-0.39%)
Bozordan keyin: Jun 26, 2026, 7:57 PM EDT
Royalty Pharma plc Qo'shma Shtatlardagi biofarmatsevtika sanoatida biofarmatsevtika royalti sotib oluvchi va innovatsiyalarni moliyalashtiruvchi sifatida faoliyat yuritadi. Uning portfeli taxminan 35 ta sotuvga chiqarilgan terapiya va rivojlanish bosqichidagi 20 ta mahsulot nomzodlaridan olingan royalti mablag'laridan iborat bo'lib, ular kam uchraydigan kasalliklar, onkologiya, nevrologiya, yuqumli kasalliklar, gematologiya va diabet kabi turli terapevtik sohalarni qamrab oladi. Kompaniya autoimmun kasalliklar uchun tadqiq qilinayotgan dori vositasi JNJ-4804ni ishlab chiqishni rag'batlantirish uchun tadqiqot va ishlanmalar moliyalash hamkorligini yo'lga qo'ygan. Kompaniya 1996 yilda tashkil etilgan va Nyu-York, Nyu-York shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
| Dr. Marshall Jonathan Urist M.D., Ph.D. | Executive Vice President of Research & Investments |
| Mr. Arthur Richard McGivern J.D. | Executive VP of Investment & Chief Legal Officer |
| Mr. Christopher Hite | Chairman of Partnering & Investments |
| Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
| Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
| Mr. Pablo Legorreta | Founder, Chairman of the Board & CEO |
| Mr. Sandy Balkin Ph.D. | Senior Vice President of Strategy & Analytics |
| Mr. Terrance P. Coyne | Executive VP & CFO |
| Ms. Molly Sawaya | Executive VP & Head of Human Capital |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-04 | 8-K | d855771d8k.htm |
| 2026-05-28 | 8-K | d131735d8k.htm |
| 2026-05-06 | 8-K | rprx-20260506.htm |
| 2026-05-06 | 10-Q | rprx-20260331.htm |
| 2026-04-13 | 8-K | d871473d8k.htm |
| 2026-04-10 | DEFA14A | ny20066979x2_defa14a.htm |
| 2026-04-10 | DEF 14A | ny20066979x1_def14a.htm |
| 2026-04-10 | ARS | ny20066979x3_ars.pdf |
| 2026-02-11 | 8-K | rprx-20260211.htm |
| 2026-02-11 | 10-K | rprx-20251231.htm |